Method and apparatus for bridging network protocols
    12.
    发明申请
    Method and apparatus for bridging network protocols 有权
    桥接网络协议的方法和装置

    公开(公告)号:US20070268929A1

    公开(公告)日:2007-11-22

    申请号:US11821073

    申请日:2007-06-21

    IPC分类号: H04L12/66 H04J3/16 H04J3/22

    摘要: Methods and apparatus for bridging network protocols are disclosed. A protocol bridge may be used to function as a target for a network processor while performing a target mode operation, while functioning as an initiator on behalf of the network processor while performing an initiator mode operation. In one embodiment, the protocol bridge determines the mode of operation based on information in a received frame's header. In another embodiment, the protocol bridge couples a Fibre Channel device to a storage processor on a packet-over-SONET network.

    摘要翻译: 公开了桥接网络协议的方法和装置。 当执行目标模式操作时,可以使用协议桥作为网络处理器的目标,同时在执行启动器模式操作时用作代表网络处理器的启动器。 在一个实施例中,协议桥基于接收帧的头部中的信息来确定操作模式。 在另一实施例中,协议桥将光纤通道设备耦合到SONET网络上的存储处理器。

    Method for Diagnosing, Prognosing and Treating Glioma
    15.
    发明申请
    Method for Diagnosing, Prognosing and Treating Glioma 审中-公开
    诊断,预后和治疗胶质瘤的方法

    公开(公告)号:US20070141066A1

    公开(公告)日:2007-06-21

    申请号:US11609071

    申请日:2006-12-11

    摘要: The invention provides generally a method of monitoring, diagnosing, prognosing and treating glioma. Specifically, the invention provides for three (3) prognostic subclasses of glioma, which are differentially associated with activation of the akt and notch signaling pathways. Tumor displaying neural or proneural PN lineage markers (including notch pathway elements) show longer median patient survival, while the two remaining tumor markers Prolif and Mes are associated with shortened survival. Tumors classified in this manner may also be treated with the appropriate PN- Prolif- or Mes-therapeutic corresponding to the subclassification in combination with anti-mitotic agents, anti-angiogenic agents, Akt antagonists, and neural differentiation agents. Alternatively, the invention also provides for method of prognosing and diagnosing glioma with a two-gene model based on the expression levels of PTEN and DLL3.

    摘要翻译: 本发明提供一种监测,诊断,预后和治疗胶质瘤的方法。 具体而言,本发明提供了三(3)个胶质瘤的预后亚类,其与akt和缺口信号传导途径的激活差异相关。 显示神经或倾向性PN谱系标志物(包括切口通路元件)的肿瘤显示较长的患者中位数,而剩余的两个肿瘤标志物Prolif和Mes与生存期缩短相关。 以这种方式分类的肿瘤也可以用与抗有丝分裂剂,抗血管生成剂,Akt拮抗剂和神经分化剂组合的对应于分类的适当的PN- Prolif-或Mes-治疗来治疗。 或者,本发明还提供了基于PTEN和DLL3的表达水平用双基因模型预测和诊断胶质瘤的方法。